IME
Imexhs Ltd
- Announcements, last 12 months
- 52
- Price sensitive, last 12 months
- 13
- Followed on InvestorPA
- Low (Outside the 20% most-followed companies on InvestorPA)
Latest announcements
| Released | Headline | Actions |
|---|---|---|
| H1 FY26 Results Presentation Price sensitive | AI summary | |
| Notification of cessation of securities - IME | ||
| Notice of 1H FY26 Results Presentation | ||
| IMEXHS Reports 1H FY26 Results Price sensitive | ||
| Half Yearly Report and Accounts Price sensitive | ||
| Quarterly Activities/Appendix 4C Cash Flow Report Price sensitive | ||
| Change in Registered Office | ||
| Resignation and Appointment of Company Secretary | ||
| Application for quotation of securities - IME | ||
| Appendix 3Y - Damian Banks |
Sign in to see all IME announcements.
Guidance history
| 2 Sep 2026 | FY26 Revenue: $31.4m to $33.7m, Underlying EBITDA: $2.4m to $2.7m | |
| 31 Oct 2025 | Revenue in the range $27.5m to $28.2m - up 4.0 to 6.6% on the prior year; and Underlying EBITDA in the range $1.3m to $1.6m - up vs $0.5m in the prior year. | |
| 2 Sep 2025 | The Company expects to achieve the following for FY25: revenue in the range $27.5m to $28.2m - up 4.0 to 6.6% vs prior year, and underlying EBITDA in the range $1.3m to $1.6m - up $0.8m to $1.1m vs prior year. |
Sign in to see the full guidance history.
Most followed in Health Care
Follow IME to get its announcements emailed to you, with AI summaries, the full announcement and guidance history, and its most significant announcements.
Sign in